Featured Research

from universities, journals, and other organizations

Malignant cells adopt different pathway for genome duplication

Date:
December 5, 2013
Source:
Université de Genève
Summary:
Genomes must be replicated in two copies during cell division. This process occurs at structures called 'replication forks', which are equipped with enzymes and move along the separated DNA strands. In tumor cells, the replication forks are frequently damaged, giving rise to breaks in the double-stranded DNA. An international study has revealed how cancer cells repair the damaged replication forks in order to complete their division.

The parental DNA (blue) opens up to allow the replication of two new strands (red). The BIR repair process leads to the aberrant duplication of DNA fragments (green).
Credit: © Thanos Halazonetis, UNIGE

Genomes must be replicated in two copies during cell division. This process occurs at structures called 'replication forks', which are equipped with enzymes and move along the separated DNA strands. In tumour cells, the replication forks are frequently damaged, giving rise to breaks in the double-stranded DNA. An international study led by Thanos Halazonetis, Professor at the Faculty of Sciences at the University of Geneva (Switzerland), has revealed how cancer cells repair the damaged replication forks in order to complete their division. The pathway used is known as 'break-induced replication' (BIR) and is common in cancer cells, but rare in healthy cells. The study described in the journal Science thus reveals a significant difference between these two types of cells, which its authors will attempt to exploit for therapeutic purposes.

For one of our cells to give birth to two daughter cells, it must first replicate its DNA which consists of around 6.4 billion pairs of nucleotides. The double-stranded DNA opens up like a zipper, producing a 'replication fork' upon which a group of enzymes move about. Present in different regions in the DNA, the forks move with the progression of the replication.

Cell proliferation is controlled in particular by specific genes known as proto-oncogenes. Their overexpression or mutation into oncogenes triggers an uncontrolled proliferation and promotes cancer development. 'In tumour cells, oncogenes induce a collapse or even a rupture of the replication forks. This causes the detachment of enzymatic replication complexes and a break of the double-stranded DNA', explains Thanos Halazonetis, Professor at the Department of Molecular Biology at the University of Geneva.

The same mechanism in yeast and malignant cells

In collaboration with the universities of Helsinki (Finland), Duisburg-Essen (Germany), Brandeis (USA) and the Karolinska Institute (Sweden), the geneticist's team has determined how the damaged forks are repaired so that replication can resume. The researchers have analysed 690 genes involved in DNA metabolism. 'We have set up a library of molecules known as siRNAs which are capable of targeting genes individually by preventing them from being expressed', reports Lorenzo Costantino, post-doctoral fellow in the team and a main author of the article.

These genetic hooks have allowed the researchers to isolate several genes essential for the repair of damaged forks, including POLD3 and POLD4. These two genes encode proteins involved in DNA replication and repair. 'Thanks to these first hits, we were able to identify a different repair process known as 'break-induced replication' (BIR), which was known in yeast, but not in humans', notes Sotirios Sotiriou, doctoral researcher of the team and co-author.

Aberrant duplication of tumour DNA

The biologists have found that the BIR repair process, rarely employed in healthy cells, is very common in human tumour cells. Furthermore, the use of this intracellular repair pathway explains how abnormal duplications of portions of the genome observed in cancer cells occur. The genome's instability is in fact essential to tumour development as it allows for the accumulation of the prerequisite mutations. 'Different proteins, such as POLD3 and POLD4, are recruited for BIR. Our next objective is to identify all the other biochemical players involved in this intracellular pathway in order to determine which ones could be a therapeutic target', explains Thanos Halazonetis.


Story Source:

The above story is based on materials provided by Université de Genève. Note: Materials may be edited for content and length.


Journal Reference:

  1. L. Costantino, S. K. Sotiriou, J. K. Rantala, S. Magin, E. Mladenov, T. Helleday, J. E. Haber, G. Iliakis, O. Kallioniemi, T. D. Halazonetis. Break-Induced Replication Repair of Damaged Forks Induces Genomic Duplications in Human Cells. Science, 2013; DOI: 10.1126/science.1243211

Cite This Page:

Université de Genève. "Malignant cells adopt different pathway for genome duplication." ScienceDaily. ScienceDaily, 5 December 2013. <www.sciencedaily.com/releases/2013/12/131205170105.htm>.
Université de Genève. (2013, December 5). Malignant cells adopt different pathway for genome duplication. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/12/131205170105.htm
Université de Genève. "Malignant cells adopt different pathway for genome duplication." ScienceDaily. www.sciencedaily.com/releases/2013/12/131205170105.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins